EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improvement of glucocorticoid sensitivity and attenuation of pulmonary allergic reactions by exogenous supplementation with betaine in HDM and LPS‐induced allergic mouse model

Qing Wang iD, Wen He, Yufeng Zhou, Yun Liu, Xiaoling Li, Yingwen Wang, Jiayu Wang, Xiao Han, Xiaobo Zhang

Clinical and Translational Allergy · 2025-02 · 15 (2)

DOI: 10.1002/clt2.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 08.02.2025. Verfasst von Qing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Children's Hospital of Fudan University, Shanghai, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Emerging Frontiers Joint Research Project of the Shanghai Hospital Development Center, Special Project for Blockchain Key Technology Research, Science & Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood asthma is a heterogeneous disease that exhibits different characteristics and varying severity; however, the metabolite alterations underlying the difference in asthma severity, especially in severe asthma, are not well understood. The aim of this study was to identify the plasma metabolic profile of children with different asthma severity and explore the potential intervention targets in severe asthma and glucocorticoid resistance.

Methods

Untargeted liquid chromatography mass spectrometry was utilized to analyze plasma metabolites in 54 children with mild‐to‐moderate asthma, 50 children with severe asthma and 39 healthy controls. Multivariate statistical analyses were used to explore plasma metabolic alterations that were strongly associated with asthma severity. Meanwhile, the severe allergic airway inflammation mice with glucocorticoid resistance were constructed to validate the potential therapeutic capacity of metabolites.

Results

The plasma metabolic profiles of children with mild to moderate asthma and severe asthma exhibited significant alterations. The distinct plasma metabolite shifts were accompanied by functional alterations in lipid metabolism, particularly choline metabolism, glycerophospholipids and sphingolipid metabolism. 11‐cis‐retinol, LysoPC (20:4 [8Z,11Z,14Z,17Z]), and glycerophosphatidylcholine were associated with exacerbated airway inflammation and lung function. Furthermore, 2‐Hydroxyestradiol, LysoPC (18:3 [6Z,9Z,12Z]), zeaxanthin, and betaine were shifted exclusively in the severe asthma group and may serve as potential biomarkers. Subsequent in vivo studies demonstrated that betaine supplementation partially improved glucocorticoid resistance.

Conclusions

Overall, children with different asthma severity displayed distinct plasma metabolic patterns. These may contribute to the difference in response to glucocorticoids in childhood asthma and could be potential targets and interventions.

Schlagwörter

Stichwörter der Autor:innen

betainecholine metabolismglucocorticoid resistancesevere asthmatherapeutic targets

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Children's Hospital of Fudan University, Shanghai, China.
  • International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institute of Pediatrics, Children's Hospital of Fudan University, and the Shanghai Key Laboratory of Medical Epigene…
  • National Health Commission (NHC) Key Laboratory of Neonatal Diseases, Fudan University, Children's Hospital of Fudan University, Shanghai, China.
  • MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Shanghai Xuhui Central Hospital, Fudan University, Shanghai, China.
  • Department of Nursing, Children's Hospital of Fudan University, Shanghai, China.
  • Guangzhou Women and Children's Medical Centre, Institute of Pediatrics, Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Qing Wang

Förderung

  • Emerging Frontiers Joint Research Project of the Shanghai Hospital Development Center
  • Special Project for Blockchain Key Technology Research, Science & Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, Q., He, W., Zhou, Y., Liu, Y., Li, X., Wang, Y., Wang, J., Han, X., & Zhang, X. (2025). Improvement of glucocorticoid sensitivity and attenuation of pulmonary allergic reactions by exogenous supplementation with betaine in HDM and LPS‐induced allergic mouse model. Clinical and Translational Allergy, 15(2). https://doi.org/10.1002/clt2.70039

Vancouver

Wang Q, He W, Zhou Y, Liu Y, Li X, Wang Y, et al. Improvement of glucocorticoid sensitivity and attenuation of pulmonary allergic reactions by exogenous supplementation with betaine in HDM and LPS‐induced allergic mouse model. Clinical and Translational Allergy. 2025;15(2). doi:10.1002/clt2.70039

BibTeX
@article{Wang2025,
  author = {Wang, Qing and He, Wen and Zhou, Yufeng and Liu, Yun and Li, Xiaoling and Wang, Yingwen and Wang, Jiayu and Han, Xiao and Zhang, Xiaobo},
  title = {Improvement of glucocorticoid sensitivity and attenuation of pulmonary allergic reactions by exogenous supplementation with betaine in HDM and LPS‐induced allergic mouse model},
  journal = {Clinical and Translational Allergy},
  year = {2025},
  volume = {15},
  number = {2},
  doi = {10.1002/clt2.70039}
}
Kostenlos starten →